Abiopharma

🔍 Whaley Glenn (Executive)

Company: IMMUNIC, INC. (IMUX)

Report Date: 2026-06-29

Detailed Transactions and Holdings:

• Acquired 120,000 shares of Stock Option at $11.6 per share (Derivative)
  Date: 2026-06-29 | Code: A | Expires: 2036-04-02 | equity_swap_involved: 0 | shares_owned_after: 120,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents options to purchase shares of common stock conditionally approved by the Board of Directors, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026.
• F2: The shares underlying this option vest 25% on April 2, 2027, and the remainder vest in equal increments on each successive one-month anniversary thereafter for the next thirty-six months.